Innocorp (531929)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹5.28 |
| Market Cap | ₹4.19 Cr |
| P/E Ratio | 0 |
| ROCE | -10% |
| ROE | -18.42% |
| Dividend Yield | 0% |
| Profit Growth | -300% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹4.22 — ₹6.05 |
| Sector | Industrial Products |
| Book Value | ₹3.24 |
Strengths
- Tiny market cap of ₹4 Cr means low expectations may already be baked into the price.
- Book value of ₹3.24 per share provides some tangible asset backing, albeit price is above it.
- 52-week range ₹4.22–₹6.05 suggests no speculative froth or euphoric buying.
- Absolute share price of ₹5.28 allows small investors to take a small position without large capital outlay.
Concerns
- Latest quarter shows sales of ₹0 Cr and net profit of ₹-0 Cr, indicating no meaningful operating activity.
- Negative ROE of -18.42% and ROCE of -10.00% confirm capital destruction.
- P/B of 1.63 means paying a premium to book value for a loss-making entity.
- Piotroski F-Score of 2/9 and profit growth of -300% signal severe financial distress.
AI Analysis
At ₹5.28, this is a ₹4 crore microcap that fails every test I would apply. A business with zero sales in the latest quarter and negative profitability cannot be valued on a P/E. ROE is -18.42% and ROCE is -10.00%, meaning it is destroying capital. The Piotroski F-Score of 2/9 confirms very weak fundamentals. There is no moat in plastic products, no pricing power, and no growth: sales growth is 0.00%, while profit growth is -300%. Book value is ₹3.24, yet I am asked to pay ₹5.28, or 1.63 times book, for a company earning no money. That is paying up for a lemon. In Graham's language, the price is not the bargain; even the asset value does not support it. The 52-week range of ₹4.22 to ₹6.05 offers no margin of safety. There is no dividend to compensate while waiting, and promoter holding is not disclosed, which itself reduces trust. This is not a business in the operating sense; it is a shell with a quotation. Some may call it a turnaround candidate because of the tiny market cap, but without sales or a credible plan, hope is not an investment strategy. I would need to see actual revenue, positive operating leverage, and a return on capital comfortably above zero before my interest is awakened. Until then, this belongs in the 'too hard' pile. I prefer paying a fair price for a wonderful business, but this is a poor business at an unattractive price. As Buffett would say, it is far better to buy a wonderful company at a fair price than a fair company at a wonderful price. Here, we have neither.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer